Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction

Nephron - Clinical Practice

Volumn 128, Issue , 2014, Pages 345-351

  Tanaka, Marenao ^a   Furuhashi, Masato ^a   Okazaki, Yusuke ^a   Mita, Tomohiro ^a   Fuseya, Takahiro ^a   Ohno, Kohei ^a   Ishimura, Shutaro ^a   Yoshida, Hideaki ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glomerular endothelial cells; Proteinuria; Renal dysfunction

Indexed keywords

CREATININE; FATTY ACID BINDING PROTEIN 4; MESSENGER RNA; TRIACYLGLYCEROL; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ADIPOCYTE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RENAL DYSFUNCTION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; BIOPSY; METABOLISM; MIDDLE AGED; PATHOLOGY;

BIOPSY; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROTEINURIA;

EID: 84918494638     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000368412     Document Type: Article

References (25)

1. Furuhashi M, Hotamisligil GS: Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008; 7: 489-503.
2. Furuhashi M, Ishimura S, Ota H, Miura T: Lipid chaperones and metabolic inflammation. Int J Inflam 2011; 2011: 642612.
3. Maatman RG, van de Westerlo EM, van Kup-pevelt TH, Veerkamp JH: Molecular identification of the liver-And the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992; 288: 285-290.
4. Kamijo-Ikemori A, Sugaya T, Kimura K: Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006; 374: 1-7.
5. Noiri E, Doi K, Negishi K, Tanaka T, Hama-saki Y, Fujita T, Portilla D, Sugaya T: Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2009; 296:F669-F679.
6. Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, Kashiwagi A, Uzu T, Maegawa H: Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 2013; 36: 1248-1253.
7. Mou S, Wang Q, Li J, Shi B, Ni Z: Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulo-nephritis. Clin Chim Acta 2012; 413: 187-191.
8. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adi-pocyte fatty acid binding protein. Science 1996; 274: 1377-1379.
9. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF: Lack of macrophage fatty-Acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001; 7: 699-705.
10. Furuhashi M, Fucho R, Gorgun CZ, Tunc-man G, Cao H, Hotamisligil GS: Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008; 118: 2640-2650.
11. Furuhashi M, Tuncman G, Gorgun CZ, Ma-kowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS: Treatment of diabetes and atherosclerosis by inhibiting fatty-Acid-binding protein aP2. Nature 2007; 447: 959-965.
12. Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S: Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 2009; 23: 3865-3873.
13. Lee MY, Tse HF, Siu CW, Zhu SG, Man RY, Vanhoutte PM: Genomic changes in regenerated porcine coronary arterial endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: 2443-2449.
14. Matsuo S, Imai E, Horio M, Yasuda Y, To-mita K, Nitta K, Yamagata K, Tomino Y, Yo-koyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
15. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehal-ly J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzen-berg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and repro-ducibility. Kidney Int 2009; 76: 546-556.
16. Iso T, Maeda K, Hanaoka H, Suga T, Goto K, Syamsunarno MR, Hishiki T, Nagahata Y, Matsui H, Arai M, Yamaguchi A, Abumrad NA, Sano M, Suematsu M, Endo K, Hotamisligil GS, Kurabayashi M: Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. Arterioscler Thromb Vasc Biol 2013; 33: 2549-2557.
17. Satchell SC, Braet F: Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 2009; 296:F947-F956.
18. Deen WM, Lazzara MJ, Myers BD: Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001; 281:F579-F596.
19. Brinkkoetter PT, Ising C, Benzing T: The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013; 9: 328-336.
20. Sun YB, Qu X, Zhang X, Caruana G, Bertram JF, Li J: Glomerular endothelial cell injury and damage precedes that of podocytes in adriam-ycin-induced nephropathy. PLoS One 2013; 8:e55027.
21. Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M: Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007; 56: 2155-2160.
22. Yuen DA, Stead BE, Zhang Y, White KE, Kabir MG, Thai K, Advani SL, Connelly KA, Takano T, Zhu L, Cox AJ, Kelly DJ, Gibson IW, Taka-hashi T, Harris RC, Advani A: eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol 2012; 23: 1810-1823.
23. Lee MY, Li H, Xiao Y, Zhou Z, Xu A, Van-houtte PM: Chronic administration of BMS309403 improves endothelial function in apolipoprotein e-deficient mice and in cultured human endothelial cells. Br J Pharmacol 2011; 162: 1564-1576.
24. Yamashita T, Fujimiya M, Nagaishi K, Ataka K, Tanaka M, Yoshida H, Tsuchihashi K, Shi-mamoto K, Miura T: Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy. FASEB J 2012; 26: 1559-1568.
25. Gorriz JL, Martinez-Castelao A: Proteinuria: detection and role in native renal disease progression. Transplant Rev (Orlando) 2012; 26: 3-13.